Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in <scp>chimeric antigen receptor T</scp> ‐cell therapy-Reference-Cited by-同舟云学术

Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T ‐cell therapy

Published:2022-10-11 Issue:1 Volume:200 Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Nakamura Naokazu¹,Arai Yasuyuki¹²³^ORCID,Kitawaki Toshio¹,Jo Tomoyasu²³^ORCID,Mizumoto Chisaki¹,Kanda Junya¹^ORCID,Nishikori Momoko¹^ORCID,Yamashita Kouhei¹^ORCID,Takaori‐Kondo Akifumi¹³^ORCID

Affiliation:

1. Department of Hematology and Oncology Graduate School of Medicine, Kyoto University Kyoto Japan

2. Department of Clinical Laboratory Medicine Graduate School of Medicine, Kyoto University Kyoto Japan

3. Center for Research and Application of Cellular Therapy Kyoto University Hospital Kyoto Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18504

Reference7 articles.

1. Efficacy and safety of CD19 ‐directed CAR‐T cell therapies in patients with relapsed/refractory aggressive B‐cell lymphomas: Observations from the JULIET , ZUMA ‐1, and TRANSCEND trials

2. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

3. Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy

4. Prognostic Significance of Cytokine Release Syndrome in B Cell Hematological Malignancies Patients After Chimeric Antigen Receptor T Cell Therapy

5. Severe electrolyte disturbances complicated by seizures and acute kidney injury within 10 days of starting indapamide;Alamin MA;Cureus,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy;Clinical and Experimental Medicine;2024-05-21

2. Clinical Impact of Cytokine Release Syndrome on Prolonged Hematotoxicity after Chimeric Antigen Receptor T Cell Therapy: KyoTox A-Score, a Novel Prediction Model;Transplantation and Cellular Therapy;2024-04

3. Hypophosphatemia and pre-infusion thrombocytopenia as biomarkers for CRS and ICANS after CAR T therapy;Bone Marrow Transplantation;2023-08-14

4. Lisocabtagene-maraleucel;Reactions Weekly;2023-04-29

5. Achievement of Team CAR-T in the clinical procedures;Japanese Journal of Transplantation and Cellular Therapy;2023